LOAN AGREEMENT among GRAYMARK HEALTHCARE, INC. SDC HOLDINGS, LLC APOTHECARYRx, LLC OLIVER COMPANY HOLDINGS, LLC ROY T. OLIVER THE ROY T. OLIVER REVOCABLE TRUST STANTON M. NELSON VAHID SALALATI GREG LUSTER KEVIN LEWIS ROGER ELY LEWIS P. ZEIDNER and...

EXHIBIT 10.31

LOAN AGREEMENT

among

GRAYMARK HEALTHCARE, INC.

SDC HOLDINGS, LLC

APOTHECARYRx, LLC

▇▇▇▇▇▇ COMPANY HOLDINGS, LLC

▇▇▇ ▇. ▇▇▇▇▇▇

THE ▇▇▇ ▇. ▇▇▇▇▇▇ REVOCABLE TRUST

▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇

▇▇▇▇▇ ▇▇▇▇▇▇▇▇

▇▇▇▇ ▇▇▇▇▇▇

▇▇▇▇▇ ▇▇▇▇▇

▇▇▇▇▇ ▇▇▇

▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇

and

ARVEST BANK

May 21, 2008

COMMERCIAL LAW GROUP, P.C.
ATTORNEYS AND COUNSELORS
700 OKLAHOMA TOWER • ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ • ▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
TELEPHONE (▇▇▇) ▇▇▇-▇▇▇▇ • TELECOPIER (▇▇▇) ▇▇▇-▇▇▇▇

		Page
1. Definition of Terms			1
1.1 Accounts			1
1.2 Borrower Subsidiaries			1
1.3 Closing Date			2
1.4 Collateral			2
1.5 Collateral Assignment of Equity Interests			2
1.6 Collateral Assignment of Leases			2
1.7 Debt Service Coverage Ratio			2
1.8 Default			2
1.9 Equipment			2
1.10 General Intangibles			3
1.11 Guaranteed Amount			3
1.12 Guaranties			3
1.13 Guarantor Pro-Rata Percentage			3
1.14 Guaranty Debt Service Coverage Ratio			3
1.15 Guaranty Reduction Trigger Date			4
1.16 Inventory			4
1.17 Loan			4
1.18 Loan Documents			4
1.19 Minimum Net Worth			4
1.20 Note			4
1.21 Obligations			5
1.22 Security Agreements			5
2. Lending Agreement			5
3. Loan			6
3.1 Term Note			6
3.1.1 Term			6
3.1.2 Interest			6
3.1.3 Payments			6
3.1.4 Voluntary Prepayment			7
3.1.5 Use of Proceeds			7
3.1.6 Place of Advances and Payments			7
3.2 Acquisition Note			7
3.2.1 Term			7
3.2.2 Interest			8
3.2.3 Payments			8
3.2.4 Voluntary Prepayment			8
3.2.5 Use of Proceeds			8
3.2.6 Place of Advances and Payments			9

Loan Agreement
Graymark Healthcare, Inc.

		Page
4. Collateral Security			9
4.1 Release of Collateral and Prior Loan Documents			9
5. Conditions of Lending			9
5.1 Loan Documents			10
5.2 Casualty Insurance			10
5.3 Authority			10
5.4 No Default			10
5.5 Commitment Fee			10
5.6 Opinion of Counsel			10
5.7 Other Information			10
6. Representations			10
6.1 Existence			10
6.2 Financial Condition			11
6.3 Liabilities			11
6.4 Ownership			11
6.5 Taxes			11
6.6 Litigation			11
6.7 Location of Business Records			11
6.8 No Default			12
6.9 Agreements Effective			12
6.10 Full Disclosure			12
6.11 Survival of Representations			12
6.12 ERISA Plans			12
6.13 Solvency			12
7. Affirmative Covenants			13
7.1 Performance of Obligations			13
7.2 Notifications			13
7.3 Records Inspections			13
7.4 Financial Information			13
7.4.1 Financial Statements			13
7.4.2 Compliance Certificate			14
7.4.3 Other Information			15
7.5 Deposit Accounts			15
7.6 Additional Documents			15
7.7 Governmental Approvals			15
7.8 Taxes			15
7.9 Access			15
7.10 Operation			16
7.11 Qualification; Licenses			16
7.12 Insurance			16

Loan Agreement
Graymark Healthcare, Inc.

		Page
8. Negative Covenants			16
8.1 Creation of Liens			16
8.2 Liquidation or Merger			16
8.3 Creation of Debt			16
8.4 Loan and Guaranties			17
8.5 Transfers			17
8.6 Other Agreements			17
8.7 Limitation on Distributions and Redemptions			17
8.8 Limitation on Investments and New Businesses			18
8.9 Transactions with Affiliates			18
8.10 Subsidiaries			18
8.11 Debt Service Coverage Ratio			18
9. Default			18
9.1 Nonpayment of Note			18
9.2 Other Nonpayment			18
9.3 Breach of Agreement			19
9.4 Lien Filings			19
9.5 Casualty Loss			19
9.6 Other Agreements			19
9.7 Representations			19
9.8 Bankruptcy			19
9.9 Judgment			19
9.10 Maturity of Other Debt			19
9.11 Failure of Liens			19
10. Remedies			20
10.1 Acceleration of Note			20
10.2 Selective Enforcement			20
10.3 Performance by Bank			20
10.4 Waiver of Default			20
10.5 Deposits; Setoff			21
11. Miscellaneous			21
11.1 Participating Lenders			21
11.2 Cumulative Remedies			21
11.3 Survival of Representations			21
11.4 Expenses			21
11.5 Notices			22
11.6 Construction			23
11.7 Binding Effect			23
11.8 No Third Party Beneficiaries			23
11.9 Assignment			23
11.10 Expiration of Agreement			23
11.11 Time			23

Loan Agreement
Graymark Healthcare, Inc.

		Page
11.12 Severability			23
11.13 Verbal Change			24
11.14 No Waiver			24
11.15 Application of Loan Proceeds			24
11.16 ACKNOWLEDGMENTS AND ADMISSIONS			24
11.17 JOINT ACKNOWLEDGMENT			25
11.18 INDEMNITY			25
11.19 WAIVER OF JURY TRIAL, PUNITIVE DAMAGES, ETC.			26

Schedule “1.5”		-		Collateral Assignment of Equity Interests
Schedule “1.6”		-		Collateral Assignment of Leases
Schedule “1.12”		-		Guaranties
Schedule “1.13”		-		Guarantor Pro-Rata Percentage
Schedule “1.20(a)”		-		Term Note
Schedule “1.20(b)”		-		Acquisition Note
Schedule “1.22”		-		Security Agreement
Schedule “4.1”		-		List of Released Loan Documents
Schedule “7.4.2”		-		Compliance Certificate

Loan Agreement
Graymark Healthcare, Inc.

LOAN AGREEMENT

          THIS LOAN AGREEMENT is made effective the 21^st day of May, 2008 among GRAYMARK HEALTHCARE, INC., an Oklahoma corporation (“GRMH”), SDC HOLDINGS, LLC, an Oklahoma limited liability company (“SDC”) and APOTHECARYRx, LLC, an Oklahoma limited liability company (“ARx” together with GRMH and SDC, jointly and severally the “Borrowers” and each a “Borrower”), ▇▇▇▇▇▇ COMPANY HOLDINGS, LLC, an Oklahoma limited liability company (“OCH”), ▇▇▇ ▇. ▇▇▇▇▇▇, an individual (“▇▇▇▇▇▇”), ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, an individual (“▇▇▇▇▇▇”), ▇▇▇ ▇. ▇▇▇▇▇▇, as Trustee (“Trustee” and together with OCH, ▇▇▇▇▇▇ and ▇▇▇▇▇▇, jointly and severally the “▇▇▇▇▇▇ Group”) of the ▇▇▇ ▇. ▇▇▇▇▇▇ Revocable Trust dated June 15, 2004 (the “Trust”), ▇▇▇▇▇ ▇▇▇▇▇▇▇▇, an individual (“Salalati”), ▇▇▇▇ ▇▇▇▇▇▇, an individual (“Luster”), ▇▇▇▇▇ ▇▇▇▇▇, an individual (“▇▇▇▇▇”) ▇▇▇▇▇ ▇▇▇, an individual (“▇▇▇”) and ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇, an individual (“▇▇▇▇▇▇▇” and together with ▇▇▇▇▇▇ Group, Salalati, ▇▇▇▇▇▇, ▇▇▇▇▇ and ▇▇▇, the “Guarantors”) and ARVEST BANK, an Arkansas banking corporation (the “Bank”).

WITNESSETH:

          WHEREAS, the Borrowers and the Guarantors have requested that the Bank loan the Borrowers funds to provide funds for the refinancing of existing indebtedness and funds for the purchase and acquisition of additional pharmacies and sleep labs, which the Bank is willing to do subject to the terms and conditions set forth in this Agreement.

          NOW, THEREFORE, in consideration of the mutual covenants and promises contained herein, the funds to be advanced by the Bank under the Notes (as hereinafter defined), the receipt and sufficiency of all of which are hereby acknowledged, the Borrower, the Guarantors and the Bank hereby agree as follows:

1. Definition of Terms. All terms defined in this Agreement will have the defined meanings when used in any of the Loan Documents (as hereinafter defined) unless the context otherwise requires. Each accounting term not defined herein, and each accounting term partly defined herein to the extent not defined, will have the meaning given to it under generally accepted accounting principles. As used in this Agreement, the following terms will have the meanings indicated:

	1.1		Accounts. All accounts, accounts receivable, contract rights, notes, drafts, acceptances and all other forms of obligations and receivables in favor of Borrower owed or owing by any party or entity to a Borrower including, but not limited to, deposits or other sums credited by or due from the Bank to a Borrower, now owned or hereafter acquired. In addition, the term “Accounts” will have the same meaning (to the extent not inconsistent with the foregoing definition) as defined in the Oklahoma Uniform Commercial Code (the “UCC”).
	1.2		Borrower Subsidiaries. The direct and indirect subsidiaries of the Borrowers as of the Closing Date, and all subsidiaries thereafter created or acquired.

Loan Agreement
Graymark Healthcare, Inc.

	1.3		Closing Date. The date upon which the Loan Documents are signed by the Borrowers and the Guarantors and accepted by the Bank at the Bank’s offices in Oklahoma City, Oklahoma, all in form and substance satisfactory to the Bank.
	1.4		Collateral. All of the Borrowers’ right, title and interest in and to the personal property described in the Loan Documents whether now owned or hereafter acquired including without limitation: (1) the Accounts; (2) the Equipment; (3) the Inventory; (4) General Intangibles, including all membership interests in SDC and ARx; (5) all items of tangible and intangible personal property now owned and hereafter acquired by a Borrower; (6) all insurance policies and proceeds; (7) all leases, rents and royalties; (8) all business records of Borrowers; and (9) all additions and accessions to, replacements of, substitutions for and proceeds from any of the items listed in the foregoing parts (a) through (h) inclusive.
	1.5		Collateral Assignment of Equity Interests. The agreement(s) to be executed by the Bank and GRMH granting to the Bank a first perfected collateral assignment of the equity interests directly or indirectly owned by GRMH in SDC and ARx, in substantially the form of Schedule “1.5” attached hereto as a part hereof.
	1.6		Collateral Assignment of Leases. The agreement(s) to be executed by the Bank and Borrowers granting to the Bank a first perfected collateral assignment of the leases of property by a Borrower utilized in the operation of its pharmacy or sleep lab businesses in substantially the form of Schedule “1.6” attached hereto as a part hereof.
	1.7		Debt Service Coverage Ratio. For any period, the ratio of: (A) the net income of GRMH (i) increased (to the extent deducted in determining net income) by the sum, without duplication, of (1) all interest expense of GRMH, (2) amortization, (3) depreciation, and (4) non-recurring expenses as approved by the Bank, and (ii) decreased (to the extent included in determining net income and without duplication) by the amount of minority interest share of net income and distributions to minority interests for taxes, if any, to (B) annual debt service including interest expense and current maturities of indebtedness as determined in accordance with generally accepted accounting principles.
	1.8		Default. The occurrence of any of the events specified in paragraph 9 of this Agreement.
	1.9		Equipment. All furniture, fixtures, machinery, tools, equipment, apparatus, utensils, appliances and supplies now owned or hereafter acquired by a Borrower and all documents of title, insurance policies and proceeds relating thereto. In addition, the term “Equipment” will have the same meaning (to the extent not inconsistent with the foregoing definition) as defined in the UCC.

Loan Agreement
Graymark Healthcare, Inc.

	1.10		General Intangibles. All of each Borrower’s general intangibles of any kind whether now existing or hereafter arising including all stock, membership interests, units, partnership interests, patents, trademarks, copyrights and other intangibles, chattel papers, documents and instruments relating to the General Intangibles. In addition, the term “General Intangibles” will have the same meaning (to the extent not inconsistent with the foregoing definition) as defined in the UCC.
	1.11		Guaranteed Amount. Initially the amount of Fifteen Million Dollars ($15,000,000.00) which shall apply to the last portion or dollars of the Obligations collected by Bank, subject to reduction on a Guaranty Reduction Trigger Date as specified therein. After a Guaranty Reduction Trigger Date, the Guaranteed Amount shall be reduced or eliminated as set forth more fully in paragraph 1.15.
	1.12		Guaranties. The agreements to be executed by the Guarantors in favor of the Bank in substantially the form of Schedule “1.12” attached hereto as a part hereof, whereby the Guarantors unconditionally guarantee to the Bank payment of all Obligations now or hereafter owing to the Bank by the Borrower in connection with the Loan Documents and the full and complete performance by the Borrower of the Loan Documents, as further set forth therein. The initial liability of each of the Guarantors thereunder will be limited to the Guarantor Pro-Rata Percentage (on a several basis) times the Guaranteed Amount, initially Fifteen Million Dollars ($15,000.000.00). On a Guaranty Reduction Trigger Date, the liability of the Guarantors will be reduced to their respective Guarantor Pro-Rata Percentage times the Guaranteed Amount as defined in paragraph 1.11. Notwithstanding any provision of this Loan Agreement to the contrary, in all events the liability of a Guarantor shall be limited as provided in the Guaranty Agreement for each Guarantor.
	1.13		Guarantor Pro-Rata Percentage. The Guarantor’s pro-rata direct or indirect ownership percentage of GRMH as of the Closing Date, as set forth in Schedule “1.13” attached hereto.
	1.14		Guaranty Debt Service Coverage Ratio. For any period, the ratio of: (A) the net income of GRMH (i) increased (to the extent deducted in determining net income) by the sum, without duplication, of (1) all interest expense of GRMH, (2) amortization, (3) depreciation, and (4) non-recurring expenses as approved by the Bank, and (ii) decreased (to the extent included in determining net income and without duplication) by the amount of minority interest share of net income and distributions to minority interests for taxes, if any, to (B) annual debt service including interest expense and current maturities of indebtedness; provided however that for purposes of this ratio the debt service shall include principal and interest on the Notes as if payable in equal monthly payments on a twenty (20) year amortization from the date of the Term Note and each respective Tranche of

Loan Agreement
Graymark Healthcare, Inc.

the Acquisition Note; all as determined in accordance with generally accepted accounting principles.

	1.15		Guaranty Reduction Trigger Date. So long as no default exists that has not been cured, the effective date of the Bank’s acceptance of the outside accountant’s financials for the Borrowers and the Borrowers’ certification of the accuracy and correctness of such financials, reflecting the Borrowers maintaining a Guaranty Debt Service Coverage Ratio, commencing with the calendar quarter ending June 30, 2008, of not less than: (i) 1.50 to 1 for four (4) consecutive calendar quarters will reduce the Guaranteed Amount to Ten Million Dollars ($10,000,000.00); (ii) 1.75 to 1 for four (4) consecutive calendar quarters will reduce the Guaranteed Amount to Five Million Dollars ($5,000,000.00); (iii) 2.00 to 1 for four (4) consecutive calendar quarters will reduce the Guaranteed Amount to zero and Bank will release such Guaranties.
	1.16		Inventory. All personal property now owned or hereafter acquired by a Borrower which are to be furnished under contracts of service, or which are raw materials, work in process, or materials used or consumed in a Borrower’s business. In addition, the term “Inventory” will have the same meaning (to the extent not inconsistent with the foregoing definition) as defined in the UCC.
	1.17		Loan. The loan by the Bank to the Borrowers evidenced by the Term Note in the principal amount of Thirty Million Dollars ($30,000,000.00) and the Acquisition Note in the Principal amount of Fifteen Million Dollars ($15,000,000.00).
	1.18		Loan Documents. This Agreement, the Collateral Assignment of Equity Interests, Collateral Assignment of Leases, the Guaranties, the Notes, the Security Agreements and all other instruments executed and delivered by the Borrowers, the Guarantors or any other person or entity in connection with the extension of credit contemplated by this Agreement, all instruments issued pursuant to the foregoing documents and all extensions, renewals, modifications and amendments thereof.
	1.19		Minimum Net Worth. Borrowers Total Net Worth as of the December 31, 2007 Financials was $1,862,882 on a consolidated basis. For purposes of this Agreement, the Borrowers’ Minimum Net Worth will be calculated on a consolidated basis based on seventy-five (75%) percent of the December 31, 2007 existing equity ($1,397,162.00) plus seventy-five (75%) percent of the Net Income (as per GAAP) for each fiscal quarter ending after December 31, 2007 on a consolidated basis, less non-recurring expenses as approved by the Bank.
	1.20		Notes. The promissory notes and all extensions, renewals, modifications, consolidations and increases thereof executed by Borrowers and delivered to the Bank pursuant to this Agreement to evidence the Loan and all advances thereunder contemplated by this Agreement for the Term Note and Acquisition

Loan Agreement
Graymark Healthcare, Inc.

Note. The Notes will be payable on the terms stated at paragraph 3 of this Agreement and will be in substantially the form of Schedule “1.20(a)” and “1.20(b)” respectively, attached hereto as a part hereof.

	1.21		Obligations. The obligation of the Borrowers to: (1) pay the principal of and interest on the Notes in accordance with the terms thereof and to satisfy all of the Borrowers’ other liabilities to the Bank, whether under this Agreement or otherwise, whether now existing or hereafter incurred, matured or unmatured, direct or contingent, joint or several, including any extensions, modifications, renewals, or increases thereof and substitutions therefor; (2) repay to the Bank all amounts advanced by the Bank under this Agreement or otherwise on behalf of the Borrowers including, without limitation, overdrafts and advances for principal or interest payments to other secured parties, mortgagees or lienors, or for taxes, levies, insurance, rent, repairs to or maintenance or storage of any of the Collateral; (3) reimburse the Bank, on demand, for all of the Bank’s expenses and costs including, without limitation, reasonable fees and expenses of the Bank’s counsel in connection with the preparation, negotiation, amendment, modification, or enforcement of this Agreement and the Loan Documents including, without limitation, any proceeding brought or threatened to enforce payment of any of the obligations referred to in this paragraph 1.21; and (4) perform all other obligations of the Borrowers under the Loan Documents.
	1.22		Security Agreements. The instruments and all extensions, renewals and modifications thereof, executed and delivered to the Bank by Borrowers or Borrower Subsidiaries granting to the Bank a first perfected security interest in and to that portion of the Collateral therein described in substantially the form of Schedule “1.22” attached hereto as a part hereof.
	1.23		WSJ Prime Rate. The rate per annum determined on the basis of the Prime rate as reported in the “Money Rates” section of The Wall Street Journal or a substitute source reasonably determined by Bank in the event such source is no longer available. The WSJ Prime Rate for each Note will initially be the WSJ Prime Rate as of the date of the Term Note or date of advance of each Tranche of the Acquisition Note, and will be adjusted on an annual basis to the rate then in effect for each Note or Tranche as of each respective anniversary date, or the first business day following such date if the anniversary date occurs on a weekend or holiday that there is no such rate determined or published.

2. Lending Agreement. Subject to the terms and conditions of this Agreement, the Bank agrees to lend to Borrowers and Borrowers agree to borrow from the Bank the principal amount of the Notes. Notwithstanding any other provision of the Loan Documents, the advances herein provided for will not be required to be made by the Bank if after making such advance, the Bank would, as determined in the sole discretion of the Bank, be in violation of any regulatory requirements imposed on banking corporations by any branch of government of the United States of America or any state

Loan Agreement
Graymark Healthcare, Inc.

thereof including, without limitation, restrictions on the scope of lending powers of state banks and limitations on total loans to any debtor imposed by the Comptroller of the Currency.

3. Loan. The Loan will be evidenced by the Term Note and Acquisition Note and will be payable as follows:

3.1

Term Note. The portion of the Loan to be made under the Term Note will be payable of the following terms:

	3.1.1		Term. The term of the Term Note will be for the period commencing on the Closing Date and ending on May 21, 2014 (the “Term Note Maturity Date”).
	3.1.2		Interest. Prior to Default, the unpaid principal balance of the Term Note will bear interest from the date of advance at the per annum rate equal to the WSJ Prime Rate, as adjusted. The WSJ Prime Rate will be adjusted, without notice, on an annual basis to the WSJ Prime Rate then in effect as of each anniversary date of this Note, or the first business day following such date if the anniversary date occurs on a weekend or holiday that there is no such rate determined or published. After Default, all amounts due under the Term Note will bear interest at the per annum rate equal to the greater of: (a) fifteen percent (15%); or (b) the WSJ Prime Rate plus five percent (5%). Interest will be computed on a per diem charge based on a three hundred sixty (360) day year.
	3.1.3		Payments. Provided that no event of Default has occurred or is continuing under any of the Loan Documents, the Term Note will be repaid in quarterly payments of interest only for up to three (3) years, then principal and interest payments based on a seven (7) year amortization until the balloon payment on the Term Note Maturity Date. The Borrowers will pay to the Lender quarterly payments of accrued and unpaid interest only on the Term Note which will be due and payable on each September 1, December 1, March 1, and June 1. Commencing on September 1, 2011, and quarterly thereafter on each December 1, March 1, June 1 and September 1, the Borrowers will pay to the Lender equal payments consisting of principal and interest calculated on a seven (7) year amortization of the unpaid principal balance of the Term Note as of June 1, 2011 at the then current WSJ Prime Rate, and adjusted annually thereafter for any changes to the WSJ Prime Rate as provided herein. The entire unpaid principal balance of the Term Note plus all accrued and unpaid interest thereon will be due and payable on the Term Note Maturity Date.

Loan Agreement
Graymark Healthcare, Inc.

	3.1.4		Voluntary Prepayment. Borrowers will have the right at any time to prepay the Term Note in whole or in part, without premium or penalty, but with interest accrued to the date of prepayment.
	3.1.5		Use of Proceeds. All proceeds of the Term Note will be used solely for the funding of (1) the acquisition and refinancing of the existing indebtedness and loans owed to Intrust Bank (the “Intrust Loan”); (2) the refinancing of the existing indebtedness owed to the Bank; and (3) other costs incurred by Borrowers or the Bank in connection with the preparation of the Loan Documents, provided that such payment is approved by the Bank.
	3.1.6		Place of Advances and Payments. Advances under the Term Note will be made at the offices of the Bank. All payments and prepayments of principal or interest on the Term Note will be made to the Bank in collected and freely transferable funds at or before 5:00 p.m. Oklahoma City, Oklahoma time on the date due at the Bank’s offices. All payments will be paid in full without set off or counterclaim and without reduction for, and free from, any and all taxes, levies, imposts, duties, fees, charges, deductions, withholdings, restrictions or conditions of any nature imposed by any government or any political subdivision or taxing authority thereof. Borrowers hereby authorize and direct the Bank to make all payments on the Term Note as and when due, by direct debit to Borrowers’ demand deposit accounts with the Bank. If any payment under the Term Note or this Agreement becomes due and payable on a day other than a business day, the maturity thereof will be extended to the next succeeding business day and such extension of time will in such case be included in the computation of payments of interest.

     3.2 Acquisition Note. The Borrowers, the Guarantors and the Bank specifically agree that the aggregate of advances made during the term of Acquisition Note will not exceed the original principal amount thereof. The Acquisition Note is an advancing term note with a commitment term through May 21, 2010 and the Bank will have no obligation to fund any advances under the Acquisition Note after such commitment term, unless renewed and extended in writing and on such terms as may be determined by the Bank. Advances under the Acquisition Note will be separately represented as a Tranche on a schedule to the Acquisition Note specifying the number of the Tranche, amount advanced, the date of advance, applicable WSJ Prime Rate and final maturity of such advance. The portion of the Loan to be made under each Tranche of the Acquisition Note will be payable on the following terms:

3.2.1

Term. The term of each Tranche of the Acquisition Note will be for the period commencing on the respective date of advance and ending on the sixth anniversary of the first day of the month following such date of advance (each a “Tranche Note Maturity Date”).

Loan Agreement
Graymark Healthcare, Inc.

	3.2.2		Interest. Prior to Default, the unpaid principal balance of each Tranche of the Acquisition Note will bear interest from the date of advance at the per annum rate equal to the WSJ Prime Rate, and will adjust for any changes to the WSJ Prime Rate on each anniversary date. The WSJ Prime Rate will be adjusted, without notice, on an annual basis to the WSJ Prime Rate then in effect as of each anniversary date of each Tranche of the Acquisition Note, or the first business day following such date if the anniversary date occurs on a weekend or holiday that there is no such rate determined or published. After Default, all amounts due under the Acquisition Note will bear interest at the per annum rate equal to the greater of: (a) fifteen percent (15%); or (b) the WSJ Prime Rate plus five percent (5%). Interest will be computed on a per diem charge based on a three hundred sixty (360) day year.
	3.2.3		Payments. Provided that no event of Default has occurred or is continuing under any of the Loan Documents, the loan represented by each Tranche will be repaid in quarterly payments of interest only for up to three (3) years, then principal and interest payments based on a seven (7) year amortization until the balloon payment on the Tranche Note Maturity Date. The Borrowers will pay to the Bank accrued and unpaid interest only at the WSJ Prime Rate in quarterly payments on each Tranche of the Acquisition Note for the first three (3) years of the term of such Tranche, which will be due and payable commencing three (3) months after the first day of the month following the date of advance and on the first day of each third month thereafter. Commencing on the third anniversary of the first quarterly payment date, and each following anniversary thereof, the principal balance outstanding on such Tranche of the Acquisition Note, together with interest at the WSJ Prime Rate on the most recent anniversary date of the date of advance under such Tranche, will be amortized in quarterly payments over a seven (7) year term beginning on the third anniversary of the date of advance, and recalculated each anniversary thereafter over the remaining portion of such seven (7) year period at the then applicable WSJ Prime Rate. The entire unpaid principal balance of the Acquisition Note plus all accrued and unpaid interest thereon will be due and payable on the respective Tranche Note Maturity Date.
	3.2.4		Voluntary Prepayment. Borrowers will have the right at any time to prepay the Acquisition Note in whole or in part, without premium or penalty, but with interest accrued to the date of prepayment.
	3.2.5		Use of Proceeds. All proceeds of the Acquisition Note will be used solely for the funding of (a) up to seventy percent (70%) of either the

Loan Agreement
Graymark Healthcare, Inc.

purchase price of the acquisition of existing pharmacy business assets or sleep labs or the startup costs of new sleep labs; and (b) other costs incurred by Borrowers or the Bank in connection with the preparation of the Loan Documents, provided that such payment is approved by the Bank. For purposes of this paragraph 3.2.5, the purchase price will include the cost of inventory purchased through the acquisition, to the extent not already included in the purchase price amount.

3.2.6

Place of Advances and Payments. Advances under the Notes will be made at the offices of the Bank. All payments and prepayments of principal or interest on each Tranche of the Acquisition Note will be made to the Bank in collected and freely transferable funds at or before 5:00 p.m. Oklahoma City, Oklahoma time on the date due at the Bank’s offices. All payments will be paid in full without set off or counterclaim and without reduction for, and free from, any and all taxes, levies, imposts, duties, fees, charges, deductions, withholdings, restrictions or conditions of any nature imposed by any government or any political subdivision or taxing authority thereof. Borrowers hereby authorize and direct the Bank to make all payments on each Tranche of the Acquisition Note as and when due, by direct debit to Borrowers’ demand deposit accounts with the Bank. If any payment under the Notes or this Agreement becomes due and payable on a day other than a business day, the maturity thereof will be extended to the next succeeding business day and such extension of time will in such case be included in the computation of payments of interest.

4. Collateral Security. Payment and performance of the Obligations will be secured by the Guaranties, the Security Agreements, Collateral Assignment of Equity Interests, Collateral Assignment of Leases, the other Loan Documents, all of the Collateral and such other or additional property as is agreed to by the Borrowers, Borrower Subsidiaries, Guarantors and the Bank, including, without limitation all loan documents evidencing and securing the Intrust Loan or indebtedness owed by any Borrower or Borrower Subsidiary to the Bank unless such documents are expressly released by the Bank.

4.1

Release of Collateral and Prior Loan Documents. Following the Closing of the Loan and receipt by Bank of all collateral documents including the Intrust Loan documents, and in consideration of the execution and delivery of the Loan Documents provided herein, Bank will release and return originals of those Intrust Loan documents and prior Bank loan documents set forth specifically on Schedule “4.1” attached hereto.

5. Conditions of Lending. The obligation of the Bank to perform this Agreement to make the initial advance under the Notes is subject to the continued performance by the Borrowers and the Guarantors of the following conditions precedent:

Loan Agreement
Graymark Healthcare, Inc.

	5.1		Loan Documents. The execution, acknowledgment (where appropriate) and delivery by the appropriate parties of the Loan Documents, all in form and substance satisfactory to the Bank, and delivery of possession to the Bank of any Collateral the possession of which is necessary to perfect the Bank’s security interest, together with the assignment of all loan documents evidencing or securing the Intrust Bank indebtedness being refinanced by this Loan.
	5.2		Casualty Insurance. The Bank will have received satisfactory certificates of policies of fire and extended coverage insurance at full insurable value, business interruption insurance and public liability insurance with premiums prepaid and standard mortgagee clauses or designations as additional insureds in favor of the Bank and such additional persons as the Bank might reasonably require.
	5.3		Authority. The Bank will have received: (1) certified copies of the instruments creating Borrowers and OCH and/or governing the operation of Borrowers and OCH complete with all amendments thereto and certificates to be filed in connection therewith; (2) satisfactory evidence that Borrowers and OCH are qualified to do business in the State of Oklahoma; and (3) certified copies of resolutions and other documents reasonably required to authorize the execution, delivery and performance of the Loan Documents by the parties thereto.
	5.4		No Default. The representations and warranties set forth in paragraph 6 of this Agreement will be true and correct on and as of the date of the initial advance of funds under the Note and there will have occurred and be continuing no Default.
	5.5		Commitment Fee. As reimbursement for processing the Loan, the Bank will have received a non-refundable fee from the Borrowers in the amount of Twenty-Five Thousand Dollars ($25,000.00).
	5.6		Opinion of Counsel. The Bank will have received the opinion of the Borrowers’ and the Guarantors’ counsel in form and substance reasonably acceptable to the Bank and the Bank’s counsel.
	5.7		Other Information. The Bank will have received current financial statements for the Borrowers and the Guarantors and such other information, documents and instruments concerning the Borrowers and the Guarantors as the Bank reasonably requests.

6. Representations. The Borrowers (and the Guarantors severally and where and as indicated below) represent and warrant to the Bank that the following circumstances exist on the date of this Agreement and will continually exist throughout the term of the Loan:

6.1

Existence. GRMH is a corporation duly organized and validly existing under the laws of the State of Oklahoma. ARx, SDC and OCH are and will each continue to be a limited liability company duly organized and validly existing under the

Loan Agreement
Graymark Healthcare, Inc.

laws of the State of Oklahoma. Borrowers and Guarantors have adequate power, authority and legal right to enter into and carry out the provisions of the Loan Documents, to borrow money and to give security for borrowings as required by this Agreement and to consummate the transactions hereby contemplated.

	6.2		Financial Condition. The financial statements of Borrowers and Guarantors, copies of which have been furnished to the Bank, are correct and complete and fairly reflect the financial condition of Borrowers and Guarantors as of the date thereof and have been prepared in conformity with accounting principles applied on a basis consistent with that of preceding periods. There has occurred no material adverse change in the financial condition of Borrowers from the date of such financial statements to the date of execution of this Agreement. Each Guarantor joins in this paragraph 6.2 on a several basis, as applicable to the Guarantor.
	6.3		Liabilities. Neither Borrowers nor any Guarantors has any material liabilities, direct or contingent, except those disclosed in the financial statements referred to in paragraph 6.2 of this Agreement. Each Guarantor joins in this paragraph 6.3 on a several basis, as applicable to the Guarantor.
	6.4		Ownership. The Borrowers have good and marketable title to the Collateral, free and clear of all liens, security interest, claims or encumbrances, except for liens and security interests in favor of the Bank.
	6.5		Taxes. The Borrowers and the Guarantors have filed all foreign, federal, state and local tax returns which are required to be filed and have paid or made provisions for payment of all taxes which have or may become due pursuant to said returns or pursuant to any assessment, except such taxes as are being contested in good faith and as to which adequate reserves have been provided. The Borrowers and the Guarantors do not know of any basis for the assessment of any deficiency taxes. Each Guarantor joins in this paragraph 6.5 on a several basis, as applicable to the Guarantor.
	6.6		Litigation. There is no action, suit, proceeding or investigation pending, or threatened against any Borrowers, any of the Guarantors or the Collateral which might: (1) adversely affect a Borrower, any of the Guarantors or the Collateral; (2) impair the ability of a Borrower to carry on their respective business as contemplated hereby; (3) result in any substantial liability not adequately covered by insurance; or (4) adversely affect a Borrower or their ability to perform their obligations under the Loan Agreement. Each Guarantor joins in this paragraph 6.6 on a several basis, as applicable to the Guarantor.
	6.7		Location of Business Records. Borrowers will give the Bank written notice of each location of each Borrower and Borrower Subsidiaries at which records pertaining to the Collateral, their business and other contract rights are kept.

Loan Agreement
Graymark Healthcare, Inc.

Except as such notice is given, all records of Borrowers pertaining to the Collateral and other contract rights are and will continue to be kept at the address of Borrowers as it appears in paragraph 11.5 of this Agreement, or at such other address as the Borrowers designate for such purpose in a written notice to the Bank. The principal place of business of each Borrower is in the State of Oklahoma.

	6.8		No Default. The execution, delivery and performance by the Borrowers and the Guarantors of this Agreement and the Loan Documents will not violate any provision or constitute a default under any indenture, agreement or instrument to which any of the Borrowers or Guarantors is a party or by which any Borrower, any Guarantor or the Collateral is bound or affected. Each Guarantor joins in this paragraph 6.8 on a several basis, as applicable to the Guarantor.
	6.9		Agreements Effective. True, correct and complete copies of the agreement creating the Trust, and each amendment thereto, have been delivered to the Bank and the agreement creating the Trust will be maintained in full force and effect.
	6.10		Full Disclosure. Neither this Agreement nor any statement or instrument referred to herein nor any other information, report or statement delivered to the Bank by the Borrowers or the Guarantors contains any untrue statement or omits to state a material fact necessary to make the statements herein or therein not misleading. Each Guarantor joins in this paragraph 6.10 on a several basis, as applicable to the Guarantor.
	6.11		Survival of Representations. All representations and warranties made by the Borrowers and the Guarantors herein will survive the delivery of the Loan Documents and the making of the Loan evidenced thereby, and any investigation at any time made by or on behalf of the Bank will not diminish the Bank’s right to rely thereon. All statements contained in any certificate or other instrument delivered by or on behalf of the Borrowers or the Guarantors under or pursuant to this Agreement or in connection with the transactions contemplated hereby will constitute representations and warranties made by the Borrowers and the Guarantors hereunder. Each Guarantor joins in this paragraph 6.11 on a several basis, as applicable to the Guarantor.
	6.12		ERISA Plans. Each of the Borrowers has disclosed to the Bank all existing employee benefit plans under the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). No termination event has occurred with respect to any ERISA plan of any Borrower and each of the Borrowers is in compliance with ERISA in all respects.
	6.13		Solvency. Upon giving effect to the issuance of the Notes, the execution of the Loan Documents by the Borrowers and the Guarantors and the consummation of the transactions contemplated hereby, the Borrowers and the Guarantors will be

Loan Agreement
Graymark Healthcare, Inc.

solvent (as such term is used in applicable bankruptcy, liquidation, receivership, insolvency or similar laws). Each Guarantor joins in this paragraph 6.13 on a several basis, as applicable to the Guarantor.

7. Affirmative Covenants. Until the payment in full of the Obligations, unless the Bank otherwise consents in writing, the Borrowers (and the Guarantors severally and where and as indicated below) agree to perform or cause to be performed the following:

	7.1		Performance of Obligations. The Borrowers will pay and perform all Obligations under the Loan Documents. The Borrowers will perform all of their respective obligations under all material contracts and agreements relating to their respective businesses, and will enforce the performance of the obligations of the other parties thereto.
	7.2		Notifications. The Borrowers will give prompt written notice to the Bank of: (1) any event of Default; (2) any event of default by a Borrower affiliate under a material contract to such affiliates portion of the Business; (3) changes of management of a Borrower; (4) the death, disability or termination of employment with a Borrower by any Guarantor; (5) all material litigation affecting any of the Borrower, Borrower affiliates, any of the Guarantors or the Collateral; (6) any notices, demands or other written communications from third party payers regarding the general coding or billing practices or asserting a pattern of improper coding or billing practices of any Borrower or any of the Borrower affiliates; (7) the change or relocation of the principal place of business of any Borrower outside the State of Oklahoma; and (8) any other matter which has resulted in, or might result in: (1) a material adverse change in the financial condition of any Borrower, the pharmacy or sleep lab businesses or any of the Guarantors, or (2) a material adverse change in the ability of the Borrowers to perform the Obligations, warranties, covenants and conditions of the Loan Documents. Each Guarantor joins in this paragraph 7.2 on a several basis, as applicable to the Guarantor.
	7.3		Records Inspections. Borrowers and Borrower Subsidiaries will each maintain full and accurate accounts and records of their respective operations on a basis consistent with prior periods. Borrowers will permit the Bank and the Bank’s designated representatives to have access to the Collateral and the records and accounts relating to the Collateral at all reasonable times to perform such inspections, audits and examinations as the Bank might reasonably request from time to time.
	7.4		Financial Information. The Borrowers and the Guarantors will furnish to the Bank (Each Guarantor joins in this paragraph 7.4 on a several basis, as applicable to the Guarantor):

7.4.1

Financial Statements. Accurate books and records of account will be kept by the Borrowers and the Guarantors in accordance with

Loan Agreement
Graymark Healthcare, Inc.

			accounting principles consistently applied. The Bank will have the right to examine and copy such books and records and the federal and state income tax returns of the Borrowers and the Guarantors, to discuss the affairs, finances and accounts of the Borrowers and the Guarantors, and to be informed as to the same at such times and intervals as the Bank might reasonably request. Borrowers will furnish to the Bank within thirty (30) days after the end of each calendar quarter commencing with the quarter ending June 30, 2008, a quarterly reviewed financial statement of Borrowers in form satisfactory to the Bank completed by Borrowers’ outside accountant, together with a certification by Borrowers as to the correctness of the Guaranty Debt Service Coverage Ratio, Debt Service Coverage Ratio and Net Worth calculations in accordance with this Agreement. In addition to the quarterly statements, Borrowers will furnish to the Bank within one hundred twenty (120) days after the close of Borrowers’ fiscal year, annual consolidated financial statements of each Borrower completed and audited by Borrowers’ outside accountant, including all consolidating entries and footnotes, starting with the calendar year 2008 and each year thereafter. The annual financial statements of Borrowers will be prepared by Borrowers in accordance with generally accepted accounting principles consistently applied, will be certified by Borrowers as to correctness and audited by Borrowers’ outside accountants and will be in form and substance satisfactory to the Bank. So long as the Guaranties remain outstanding, Guarantors will each furnish to the Bank annual financial statements within one hundred twenty (120) days after the close of each respective Guarantor’s fiscal year. The financial statements of Guarantors will be prepared in accordance with accounting principles consistently applied and will be certified by each respective Guarantor to the Bank, and will be in form and substance satisfactory to the Bank. In addition after an event of Default, the Guarantors will furnish financial statements to the Bank within fifteen (15) days after written request by the Bank. For each year in which any Obligations are outstanding, the Borrowers and the Guarantors (as to Guarantors until release of the Guaranties) will furnish to the Bank within fifteen (15) days of filing complete copies of all federal and state income tax returns of the Borrowers and the Guarantors for the preceding year with all schedules attached. If the time for filing any such tax returns is to be extended, the Borrowers and the Guarantors will provide to the Bank copies of such extensions with evidence that such extensions have been timely filed, within fifteen (15) days of filing.
	7.4.2		Compliance Certificate. The Borrowers will deliver to the Bank within thirty (30) days of the end of each fiscal quarter commencing June 1, 2008, and more frequently on the Bank’s request, a certificate

Loan Agreement
Graymark Healthcare, Inc.

in the form attached hereto as Schedule “7.4.2” stating that the Borrowers know of no event of Default under any of the Loan Documents and that all requirements of the Loan Documents have been fully performed, or if to the knowledge of any Borrower any of the terms of any of the Loan Documents have not been fully performed, such certificate will specify the nature of the Default and the steps taken by the Borrowers to correct such Default.

7.4.3

Other Information. At the Bank’s request from time to time, the Borrowers and the Guarantors (as to Guarantors until release of the Guaranties) will provide the Bank with such other information as the Bank may reasonably request regarding the business affairs and financial condition of the Borrowers and the Guarantors and the Borrowers and the Guarantors will provide access to the Bank at all reasonable times to all documents and information relating to the Collateral, the Borrower Subsidiaries and the pharmacy and sleep lab businesses.

	7.5		Deposit Accounts. The Borrowers will use their reasonable efforts to maintain their respective primary banking and deposit accounts with the Bank.
	7.6		Additional Documents. The Borrowers and the Guarantors will promptly, on demand by the Bank, perform or cause to be performed such actions and execute or cause to be executed all such additional agreements, contracts, indentures, documents and instruments as might be reasonably requested by the Bank to satisfy the requirements of this Agreement and the disbursement of funds hereunder. Each Guarantor joins in this paragraph 7.6 on a several basis, as applicable to the Guarantor.
	7.7		Governmental Approvals. Borrowers or Borrower Subsidiaries will each obtain all permits, licenses, and necessary approvals from governmental authorities and abutting landowners which are considered necessary for the proper operation of their respective businesses.
	7.8		Taxes. All taxes, assessments, governmental charges and levies imposed on the Borrowers and the Guarantors or the Borrowers’ or the Guarantors’ assets, income and profits will be paid prior to the date on which penalties attach thereto, provided that the Borrowers and the Guarantors will not be required to pay any such charge which is being contested in good faith by proper proceedings as to which adequate reserves have been established. Each Guarantor joins in this paragraph 7.8 on a several basis, as applicable to the Guarantor.
	7.9		Access. Any representative of the Bank will have reasonable access to the Collateral and any other property owned by the Borrowers.

Loan Agreement
Graymark Healthcare, Inc.

	7.10		Operation. The Borrowers agree to operate the pharmacy and sleep lab businesses directly, or indirectly through the Borrower Subsidiaries in a prudent and efficient manner consistent with normal industry practices and all governing laws and regulations.
	7.11		Qualification; Licenses. Borrowers will take such actions or cause such actions to be taken as might be required to maintain the existence of all governmental and private permits, licenses and authorities of the Borrowers and Borrower Subsidiaries, necessary or desirable to the continuation of the pharmacy and sleep lab businesses and will comply with all statutes and governmental regulations.
	7.12		Insurance. Policies of insurance will be continuously maintained by the Borrowers on the Collateral with companies, in amounts equal to the replacement cost of such Collateral, with business interruption, valuable documents and account receivable loss coverage and against risks satisfactory to the Bank. The Borrowers will furnish the Bank with copies of all certificates of insurance policies in effect and evidence of payment of the premium for each insurance policy.

8. Negative Covenants. The Borrowers (and the Guarantors severally and where and as indicated below until release of the Guaranties) agree that until payment in full of the Obligations, unless the Bank waives compliance in writing:

	8.1		Creation of Liens. Neither any Borrower nor any of Borrower Subsidiaries will create, assume or suffer to exist any trust deed, mortgage, pledge, security interest, encumbrance or other lien (including the lien of an attachment, judgment or execution) securing a charge or obligation affecting any or all of the Collateral or Accounts of the Borrower Subsidiaries, excluding only: (1) liens for governmental charges which are not delinquent or the validity of which is being contested in good faith by appropriate proceedings and as to which adequate reserves have been established under generally accepted accounting principles; (2) deposits made to secure statutory and other obligations incurred in the ordinary course of the Borrowers’ respective businesses; (3) equipment acquisition leases in the ordinary course of business; and (4) liens to the Bank contemplated by this Agreement.
	8.2		Liquidation or Merger. Neither the Borrowers nor any of Borrower Subsidiaries will liquidate, dissolve or enter into any consolidation, merger, partnership, joint venture, syndicate, pool, operating agreement or other combination, or convey, sell or assign any substantial part of their respective assets.
	8.3		Creation of Debt. Neither the Borrowers nor any of Borrower Subsidiaries will incur, create or suffer to exist any indebtedness for borrowed money, or issue, discount or sell any obligation of the Borrowers or Borrower Subsidiaries, excluding only: (1) the indebtedness to the Bank contemplated by this Agreement;

Loan Agreement
Graymark Healthcare, Inc.

(2) current accounts payable arising in the ordinary course of their respective businesses; and (3) an amount not to exceed $100,000.00 each incurred in the ordinary course of business by SDC and Arx, including their respective subsidiaries, for a total not to exceed $200,000.00; and (4) such other indebtedness as the Bank specifically approves in writing.

	8.4		Loan and Guaranties. Neither the Borrowers nor any of Borrower Subsidiaries will make any loans, advances or extensions of credit to any person, firm or corporation nor become a guarantor or surety directly or indirectly, except that Borrowers may make short term operating advances or loans to Borrower Subsidiaries in the ordinary course of business.
	8.5		Transfers. The Borrowers will not transfer or permit to be transferred voluntarily or by operation of law any interest in the Collateral, the Borrowers Subsidiaries or assets of the Borrower Subsidiaries; provided however the Borrowers, with notice to Bank, may recognize transfers of existing minority equity interests held by third parties in Borrowers Subsidiaries so long as Borrowers’ equity or ownership interest therein is not decreased. GRMH holds and will maintain at all times ownership and distributable equity interest, directly or indirectly, in SDC and ARx of not less than one hundred percent (100%). The Borrowers may create or activate currently inactive Borrower Subsidiaries so long as the Borrowers maintain the ownership and distributable equity interests percentages of not less than 51% as to new Borrower Subsidiaries and provides notice to Bank thereof and delivers such additional assignments or amendments to the Loan Documents satisfactory to the Bank covering such interests. Borrowers will not issue or sell any additional membership interests in SDC, ARx or Borrowers Subsidiaries or any other securities convertible into equity of such entities. The Guarantors will not sell, transfer or otherwise dispose of or create, assume or suffer to exist any pledge, lien, security interest, charge or encumbrance on, any interest in GRMH owned by the respective Guarantor which exceeds, in one or an aggregate of transactions, twenty percent (20%) of the respective interest currently owned, except after notice to Bank pursuant to this Loan Agreement without any approval right implied. The Guarantors will not sell, transfer or permit to be transferred voluntarily or by operation of law assets owned by such Guarantor which will materially impair the financial worth of such Guarantor or the Bank’s ability to collect the amount of Obligations guaranteed by such Guarantor. Each Guarantor joins in this paragraph 8.5 on a several basis, as applicable to the Guarantor.
	8.6		Other Agreements. The Borrowers and Guarantors will not enter into any agreement that limits or restricts the ability of the Borrowers or Guarantors to comply with the terms of the Loan Documents. Each Guarantor joins in this paragraph 8.6 on a several basis, as applicable to the Guarantor
	8.7		Limitation on Distributions and Redemptions. After the occurrence of an event of Default, Borrower will not declare, pay or make any dividend or distribution

Loan Agreement
Graymark Healthcare, Inc.

directly or indirectly in respect of any stockholder or equity interest or other interest in GRMH. GRMH will not directly or indirectly make any capital contribution to or purchase, redeem, acquire or retire any stockholder or equity interest in GRMH (whether such interest is now or hereafter issued, outstanding or created) except with prior written consent and approval of the Bank.

	8.8		Limitation on Investments and New Businesses. None of Borrowers will: (1) make any expenditure or commitment or incur any obligation or enter into or engage in any transaction except in the ordinary course of business; (2) engage directly or indirectly in any business or conduct any operations except in connection with or incidental to their respective present businesses and operations; or (3) make any acquisitions of or capital contributions to or other investments in any person or entity, other than the planned and disclosed expansion of the pharmacy and sleep lab businesses.
	8.9		Transactions with Affiliates. No Borrower will engage in any material transaction with any affiliate of a Borrower on terms which are less favorable to the Borrower than those which would have been obtainable at the time in an arm’s-length dealing with persons other than such affiliates.
	8.10		Subsidiaries. None of the Borrowers will create or own any subsidiary without the prior written notice to the Bank including the name, state of organization, list of equity holders, principal place of business and intended purpose, geographical area and scope of business operations. Borrowers agree to cause the execution and delivery of such documents to collaterally assign the Borrower’s equity interest therein and to pledge, encumber or grant a security interest in such subsidiaries’ assets.
	8.11		Debt Service Coverage Ratio. During the term of the Loan, Borrowers will continuously maintain a Debt Service Coverage Ratio of not less than 1.25 to 1.
	8.12		Minimum Net Worth. During the term of the Loan, Borrowers will continuously maintain the Minimum Net Worth determined on a quarterly basis.

9. Default. The Bank may declare the Notes and all other indebtedness and Obligations of the Borrowers owing to the Bank to be due and payable if any of the following events occur and are not remedied by the Borrowers or waived by the Bank in writing:

	9.1		Nonpayment of Note. A default in payment when due of any interest on or principal of the Note; or
	9.2		Other Nonpayment. A default in payment when due of any other amount payable to the Bank under the terms of any of the Loan Documents; or

Loan Agreement
Graymark Healthcare, Inc.

	9.3		Breach of Agreement. A default by a Borrower or a Guarantor in the performance or observance of any agreement contained in the Loan Documents, or under the terms of any other instrument delivered to the Bank in connection with this Agreement; or
	9.4		Lien Filings. The existence of any lien on the Collateral without indemnification therefor satisfactory to the Bank, except as allowed in writing by the Bank; or
	9.5		Casualty Loss. Substantial damage to or destruction of a material portion of the Collateral or the pharmacy or sleep lab businesses; or
	9.6		Other Agreements. The rescission, abandonment, disclaimer or breach of the Loan Agreement, a Guaranty or any of the other Loan Documents or other contracts or agreements pledged to the Bank under the Loan Documents; or
	9.7		Representations. Any representation, statement, certificate, schedule or report made or furnished to the Bank by the Borrowers or the Guarantors proves to be false or erroneous in any material respect at the time of the making thereof or any representation or warranty ceases to be complied with in any material respect; or
	9.8		Bankruptcy. A Borrower or any of the Guarantors becomes bankrupt or makes a general assignment for the benefit of creditors or applies for, or consents to, the appointment of a trustee, receiver or liquidator or authorizes such application or consent, or if proceedings seeking such appointment are commenced against a Borrower or a Guarantor and remain undismissed and unstayed for ninety (90) days; or a Borrower or any of the Guarantors authorizes or files a voluntary petition in bankruptcy or applies for or consents to the application of any bankruptcy, reorganization, readjustment of debt, insolvency, dissolution, liquidation or other similar law of any jurisdiction; or
	9.9		Judgment. Entry by any court of judgment against any of the Borrowers or any of the Guarantors in excess of Fifty Thousand Dollars ($50,000.00) which is not adequately covered by insurance or secured by a supersedes bond, or any attachment of any of the Collateral which is not discharged to the satisfaction of the Bank within thirty (30) days thereof; or
	9.10		Maturity of Other Debt. The occurrence of an event of default under or the acceleration of the maturity of any other indebtedness of a Borrower or a Guarantor to any other person which in the reasonable opinion of the Bank will materially and adversely affect the ability of a Borrower or a Guarantor, as applicable, to perform the Loan Documents; or
	9.11		Failure of Liens. Failure of the Bank’s assignment, liens and security interests covering the Collateral to constitute a first and prior perfected lien on any material portion of the Collateral.

Loan Agreement
Graymark Healthcare, Inc.

9.12

Stock Suspension. The suspension of trading for more than thirty (30) days or delisting of the stock of GRMH from the OC:BB or such future exchange on which the stock is hereafter listed and traded.

In the event a Borrower or a Guarantor, as applicable, cures or causes to be cured such Default within ten (10) days [five (5) days with regard to paragraph 9.11] after receipt of written notice thereof, the parties will be restored to their respective rights and obligations under this Agreement as if no Default had occurred, except that no right to cure or notice of Default will be given as to events of Default in paragraphs 9.1, 9.2, 9.8 or 9.9; provided, however that Bank agrees to give a written notice to Borrowers only without copy to counsel and five (5) days opportunity to cure for up to three (3) events of Default in paragraphs 9.1 or 9.2 during the term of this Agreement.

10. Remedies. In the event of Default, the Bank will have the following remedies:

	10.1		Acceleration of Note. The Bank may, at the Bank’s option, declare the Notes and all other Obligations to be immediately due and payable and the Bank will be entitled to proceed to selectively and successively enforce the Bank’s rights under the Loan Documents or any one or more of them.
	10.2		Selective Enforcement. In the event the Bank elects to selectively and successively enforce the Bank’s rights under any one or more of the instruments securing payment of the Obligations, such action will not be deemed a waiver or discharge of any other lien or encumbrance securing payment of the Obligations until such time as the Bank has been paid in full all sums owing to the Bank.
	10.3		Performance by Bank. The Bank will have the right (but not the obligation) to: (1) take possession of the Collateral and operate or dispose of the Collateral in such manner as the Bank determines in the Bank’s sole discretion; (2) take possession of all Accounts. Equipment, Inventory, General Intangibles, materials and tools used in any Borrower’s businesses; (3) make payments of the costs directly to persons engaged by a Borrower or the Bank; (4) make such payments and perform such acts as might be determined by the Bank to be necessary or appropriate to perform or to cure any default in performance by the Borrowers under agreements affecting the Collateral; and (5) make advances under the Notes without the consent of the Borrowers to pay interest accrued thereon and all costs. If the Bank exercises such option, all costs will be paid to the Bank by the Borrowers. The Borrowers and the Guarantors hereby authorize the Bank to increase the indebtedness owing by the Borrowers to the Bank and agree that the Loan Documents will evidence and secure payment of such costs whether or not the total funds advanced exceed the face amount of the Loan Documents.
	10.4		Waiver of Default. The Bank may, by an instrument in writing signed by the Bank, waive any Default which has occurred and any of the consequences of such Default, and in such event, the Bank, the Borrowers and the Guarantors will be restored to their respective former positions, rights and obligations hereunder.

Loan Agreement
Graymark Healthcare, Inc.

Any Default so waived will, for the purposes of this Agreement, be deemed to have been cured and not to be continuing, but no such waiver will extend to any subsequent or other Default or impair any consequence of such subsequent or other Default.

10.5

Deposits; Setoff. Regardless of the adequacy of any other collateral security held by the Bank, any deposits or other sums credited by or due from the Bank to the Borrowers or the Guarantors will at all times constitute collateral security for all indebtedness and obligations of the Borrowers and the Guarantors to the Bank and may be set off against any and all liabilities of the Borrowers and the Guarantors to the Bank. The rights granted by this paragraph are in addition to the rights of the Bank under any statutory banker’s lien now or hereafter in effect.

11. Miscellaneous. It is further agreed as follows:

	11.1		Participating Lenders. The Borrowers and the Guarantors agree that although the Loan Documents name the Bank as the holder thereof, the Bank is authorized to sell participation interests in all or any portion of the Loan to other financial institutions (a “Participating Lender”) and the Borrowers and the Guarantors agree that, subject to the terms of the agreements of participation, each Participating Lender will be entitled to rely on the terms of the Loan Documents as if the Participating Lender had been named as an original party to the Loan Documents.
	11.2		Cumulative Remedies. No failure on the part of the Bank to exercise and no delay in exercising any right hereunder will operate as a waiver thereof, nor will any single or partial exercise by the Bank of any right hereunder preclude any other or further right of exercise thereof or the exercise of any other right.
	11.3		Survival of Representations. All representations and warranties made herein will survive the making of the Loan hereunder and the delivery of the Loan Documents.
	11.4		Expenses. Within ten (10) days after receipt of invoice therefor, the Borrowers will (except where prohibited by applicable law) pay all reasonable expenses incurred by the Bank in connection with the transactions herein contemplated including, without limitation, negotiation and preparation of the Loan Documents and all attorneys’ fees, filing fees and recording costs. In addition, the Borrowers will pay all reasonable fees, costs, expenses (including legal expenses and attorneys’ fees) and disbursements of the Bank incident to: (1) the protection of the rights of the Bank in connection with the Loan Documents and the transactions contemplated thereby; and (2) the collection or enforcement of the Loan Documents whether by judicial proceedings, proceedings under Chapter 7 or 11 of the Bankruptcy Code or any successor statute thereto, or otherwise.

Loan Agreement
Graymark Healthcare, Inc.

11.5

Notices. Any notice, demand or communication required or permitted to be given by any provision of this Agreement will be in writing and will be deemed to have been given and received when delivered personally or by telefacsimile to the party designated to receive such notice, or on the date following the day sent by overnight courier, or on the third (3rd) business day after the same is sent by certified mail, postage and charges prepaid, directed to the following addresses or to such other or additional addresses as any party might designate by written notice to the other parties:

		The Bank:		Arvest Bank
				Attention: ▇▇. ▇▇▇▇▇ ▇▇▇▇
				▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
				▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
				Fax: (▇▇▇) ▇▇▇-▇▇▇▇
		with copy to:		▇▇▇ ▇▇▇▇, Esquire
				Commercial Law Group, P.C.
				700 Oklahoma Tower
				▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇
				▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
				Fax: (▇▇▇) ▇▇▇-▇▇▇▇
				The Borrower: Graymark Healthcare, Inc.
				Attention: ▇▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
				▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇
				▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
				Fax: (▇▇▇) ▇▇▇-▇▇▇▇
		with copy to:		▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇, PLLC
				▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇
				▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
				Fax: (▇▇▇) ▇▇▇-▇▇▇▇
		The Guarantors:		▇▇▇▇▇▇ Company Holdings, LLC
				▇▇. ▇▇▇ ▇. ▇▇▇▇▇▇
				▇▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
				▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇
				▇▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
				Fax: (▇▇▇) ▇▇▇-▇▇▇▇

Loan Agreement
Graymark Healthcare, Inc.

				▇▇. ▇▇▇▇▇ ▇▇▇▇▇▇▇▇
				▇▇▇ ▇. ▇▇▇▇▇▇
				▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇
				Fax: (▇▇▇) ▇▇▇-▇▇▇▇
				▇▇. ▇▇▇▇▇ ▇▇▇▇▇▇▇
				▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇
				▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
				Fax: (▇▇▇) ▇▇▇-▇▇▇▇

	11.6		Construction. The Loan Documents are intended to constitute contracts made under the laws of the State of Oklahoma and to be construed in accordance with the internal laws of said state. Nothing in this Agreement will be construed to constitute the Bank as a joint venturer with any of the Borrowers or Guarantors or to constitute a partnership. The descriptive headings of the paragraphs of this Agreement (except the terms defined at paragraph 1 hereof) are for convenience only and are not to be used in the construction of the content of this Agreement. This Agreement may be executed in multiple counterparts, each of which will constitute one agreement.
	11.7		Binding Effect. This Agreement will be binding on and will inure to the benefit of the Bank, the Borrowers, the Guarantors and their respective successors and assigns.
	11.8		No Third Party Beneficiaries. Nothing in this Agreement, express or implied, is intended to confer upon any person, other than the parties hereto and their respective successors and assigns, any rights or remedies under or by reason of this Agreement or to constitute such person a third party beneficiary of this Agreement.
	11.9		Assignment. Neither this Agreement, the Loan Documents nor the proceeds from the Loan will be assigned without the Bank’s prior written consent, and without such consent, there will be no right to designate a payee of the proceeds from the Loan.
	11.10		Expiration of Agreement. If the initial disbursement under the Term Note has not been advanced by June 15, 2008, the obligation of the Bank to make advances under the Notes pursuant to this Agreement will, at the option of the Bank, terminate on such date.
	11.11		Time. Time is of the essence of this Agreement and each provision of the other Loan Documents.
	11.12		Severability. In case any one or more of the provisions contained in the Loan Documents should be invalid, illegal or unenforceable in any respect in any

Loan Agreement
Graymark Healthcare, Inc.

jurisdiction, the validity, legality and enforceability of such provision or provisions will not in any way be affected or impaired thereby in any other jurisdiction; and the validity, legality and enforceability of the remaining provisions contained herein and therein will not in any way be affected or impaired thereby.

	11.13		Verbal Change. The Loan Documents may not be amended, altered, modified or changed verbally, but only by an agreement in writing signed by the party against whom enforcement of any amendment, waiver, change, modification or discharge is sought.
	11.14		No Waiver. No advance of the proceeds from the Loan under any of the Loan Documents will constitute a waiver of any of the representations, warranties, conditions or covenants of the Borrowers or any of the Guarantors under the Loan Documents. In the event the Borrowers or any of the Guarantors is unable to satisfy any warranty, condition or covenant contained in the Loan Documents, no advance of the proceeds from the Loan will preclude the Bank from thereafter declaring such inability to be an event of Default.
	11.15		Application of Loan Proceeds. The Bank may apply the proceeds from the Loan under the Notes to the satisfaction of any condition, warranty or covenant of the Borrowers under any of the Loan Documents, and any proceeds so applied will be considered as a part of the proceeds from the Loan advanced under the Notes and will be secured by the Loan Documents.
	11.16		ACKNOWLEDGMENTS AND ADMISSIONS. EACH OF THE BORROWERS AND GUARANTORS HEREBY REPRESENT, WARRANT, ACKNOWLEDGE AND ADMIT THAT (A) EACH OF THEM HAS MADE AN INDEPENDENT DECISION TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS TO WHICH IT IS A PARTY, WITHOUT RELIANCE ON ANY REPRESENTATION, WARRANTY, COVENANT OR UNDERTAKING BY THE BANK, WHETHER WRITTEN, ORAL OR IMPLICIT, OTHER THAN AS EXPRESSLY SET OUT IN THIS AGREEMENT OR IN ANOTHER LOAN DOCUMENT DELIVERED ON OR AFTER THE DATE HEREOF, (B) THERE ARE NO REPRESENTATIONS, WARRANTIES, COVENANTS, UNDERTAKINGS OR AGREEMENTS BY THE BANK AS TO THE LOAN DOCUMENTS EXCEPT AS EXPRESSLY SET OUT IN THIS AGREEMENT OR IN ANOTHER LOAN DOCUMENT DELIVERED ON OR AFTER THE DATE HEREOF, (C) THE BANK HAS NO FIDUCIARY OBLIGATION TOWARD THE BORROWERS OR THE GUARANTORS WITH RESPECT TO ANY LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED THEREBY, (D) THE RELATIONSHIP PURSUANT TO THE LOAN DOCUMENTS BETWEEN THE BORROWERS AND THE BANK IS AND WILL BE SOLELY THAT

Loan Agreement
Graymark Healthcare, Inc.

OF DEBTOR AND CREDITOR, (E) NO PARTNERSHIP OR JOINT VENTURE EXISTS WITH RESPECT TO THE LOAN DOCUMENTS BETWEEN ANY BORROWER OR THE GUARANTORS AND THE BANK, (F) SHOULD A DEFAULT OCCUR OR EXIST, THE BANK WILL DETERMINE IN ITS SOLE DISCRETION AND FOR ITS OWN REASONS WHAT REMEDIES AND ACTIONS IT WILL OR WILL NOT EXERCISE OR TAKE AT THE TIME, (G) WITHOUT LIMITING ANY OF THE FOREGOING, NO BORROWER OR GUARANTOR IS RELYING UPON ANY REPRESENTATION OR COVENANT BY THE BANK, OR ANY REPRESENTATIVE THEREOF, AND NO SUCH REPRESENTATION OR COVENANT HAS BEEN MADE, THAT THE BANK WILL, AT THE TIME OF AN EVENT OF DEFAULT, OR AT ANY OTHER TIME, WAIVE, NEGOTIATE, DISCUSS OR TAKE OR REFRAIN FROM TAKING ANY ACTION PERMITTED UNDER THE LOAN DOCUMENTS WITH RESPECT TO ANY SUCH EVENT OF DEFAULT OR ANY OTHER PROVISION OF THE LOAN DOCUMENTS, AND (H) THE BANK HAS RELIED UPON THE TRUTHFULNESS OF THE ACKNOWLEDGMENTS IN THIS PARAGRAPH 11.16 IN DECIDING TO EXECUTE AND DELIVER THIS AGREEMENT AND TO BECOME OBLIGATED HEREUNDER.

	11.17		JOINT ACKNOWLEDGMENT. THIS WRITTEN AGREEMENT AND THE OTHER LOAN DOCUMENTS REPRESENT THE FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS BETWEEN THE PARTIES.
	11.18		INDEMNITY. THE BORROWERS AGREE TO INDEMNIFY THE BANK, UPON DEMAND, FROM AND AGAINST ANY AND ALL LIABILITIES, OBLIGATIONS, CLAIMS, LOSSES, DAMAGES, PENALTIES, FINES, ACTIONS, JUDGMENTS, SUITS, SETTLEMENTS, COSTS, EXPENSES OR DISBURSEMENTS (INCLUDING REASONABLE FEES OF ATTORNEYS, ACCOUNTANTS, EXPERTS AND ADVISORS) OF ANY KIND OR NATURE WHATSOEVER (IN THIS PARAGRAPH COLLECTIVELY CALLED “LIABILITIES AND COSTS”) WHICH TO ANY EXTENT (IN WHOLE OR IN PART) MAY BE IMPOSED ON, INCURRED BY, OR ASSERTED AGAINST THE BANK BY THIRD PARTIES GROWING OUT OF, RESULTING FROM OR IN ANY OTHER WAY ASSOCIATED WITH THE COLLATERAL, THE LOAN DOCUMENTS AND THE TRANSACTIONS AND EVENTS (INCLUDING THE ENFORCEMENT OR DEFENSE THEREOF) AT ANY TIME ASSOCIATED THEREWITH OR CONTEMPLATED THEREIN (WHETHER ARISING IN CONTRACT OR TORT OR OTHERWISE AND

Loan Agreement
Graymark Healthcare, Inc.

INCLUDING ANY VIOLATION OR NONCOMPLIANCE WITH ANY ENVIRONMENTAL LAWS BY THE BORROWERS, THE GUARANTORS OR THE BANK OR ANY LIABILITIES OR DUTIES OF THE BORROWERS, THE GUARANTORS OR THE BANK WITH RESPECT TO HAZARDOUS MATERIALS FOUND IN OR RELEASED INTO THE ENVIRONMENT).

			THE FOREGOING INDEMNIFICATION WILL APPLY WHETHER OR NOT SUCH LIABILITIES AND COSTS ARE IN ANY WAY OR TO ANY EXTENT OWED, IN WHOLE OR IN PART, UNDER ANY CLAIM OR THEORY OF STRICT LIABILITY, OR ARE CAUSED, IN WHOLE OR IN PART, BY ANY NEGLIGENT ACT OR OMISSION OF ANY KIND BY THE BANK, PROVIDED ONLY THAT THE BANK WILL NOT BE ENTITLED UNDER THIS PARAGRAPH TO RECEIVE INDEMNIFICATION FOR THAT PORTION, IF ANY, OF ANY LIABILITIES AND COSTS WHICH IS PROXIMATELY CAUSED BY ITS OWN INDIVIDUAL GROSS NEGLIGENCE OR WILLFUL MISCONDUCT, AS DETERMINED IN A FINAL JUDGMENT. IF ANY PERSON (INCLUDING ANY BORROWER, ANY OF THEIR AFFILIATES OR ANY GUARANTOR) EVER ALLEGES SUCH GROSS NEGLIGENCE OR WILLFUL MISCONDUCT BY THE BANK, THE INDEMNIFICATION PROVIDED FOR IN THIS PARAGRAPH WILL NONETHELESS BE PAID UPON DEMAND, SUBJECT TO LATER ADJUSTMENT OR REIMBURSEMENT, UNTIL SUCH TIME AS A COURT OF COMPETENT JURISDICTION ENTERS A FINAL JUDGMENT AS TO THE EXTENT AND EFFECT OF THE ALLEGED GROSS NEGLIGENCE OR WILLFUL MISCONDUCT. AS USED IN THIS PARAGRAPH THE TERM “BANK” WILL REFER NOT ONLY TO THE PERSON DESIGNATED AS SUCH BUT ALSO TO EACH DIRECTOR, OFFICER, AGENT, ATTORNEY, EMPLOYEE, PARTICIPANT, REPRESENTATIVE AND AFFILIATE OF THE BANK.
	11.19		WAIVER OF JURY TRIAL, PUNITIVE DAMAGES, ETC. EACH OF THE BORROWERS, THE BORROWER SUBSIDIARIES, THE GUARANTORS AND THE BANK HEREBY KNOWINGLY, VOLUNTARILY, INTENTIONALLY AND IRREVOCABLY (A) WAIVES, TO THE MAXIMUM EXTENT NOT PROHIBITED BY LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY A JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR DIRECTLY OR INDIRECTLY AT ANY TIME ARISING OUT OF, UNDER OR IN CONNECTION WITH THE LOAN DOCUMENTS OR ANY TRANSACTION CONTEMPLATED THEREBY OR ASSOCIATED THEREWITH, BEFORE OR AFTER MATURITY, (B) WAIVES, TO THE MAXIMUM EXTENT NOT PROHIBITED BY LAW, ANY RIGHT IT MAY HAVE TO CLAIM OR RECOVER IN ANY SUCH LITIGATION ANY “SPECIAL DAMAGES,”

Loan Agreement
Graymark Healthcare, Inc.

AS DEFINED BELOW, (C) CERTIFIES THAT NO PARTY HERETO NOR ANY REPRESENTATIVE OR COUNSEL FOR ANY PARTY HERETO HAS REPRESENTED, EXPRESSLY OR OTHERWISE, OR IMPLIED THAT SUCH PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVERS, AND (D) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT, THE OTHER LOAN DOCUMENTS AND THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS CONTAINED IN THIS PARAGRAPH. AS USED IN THIS PARAGRAPH, “SPECIAL DAMAGES” INCLUDES ALL SPECIAL, CONSEQUENTIAL, EXEMPLARY OR PUNITIVE DAMAGES (REGARDLESS OF HOW NAMED), BUT DOES NOT INCLUDE ANY PAYMENTS OR FUNDS WHICH ANY PARTY HERETO HAS EXPRESSLY PROMISED TO PAY OR DELIVER TO ANY OTHER PARTY HERETO.

[SIGNATURE PAGES TO FOLLOW]

Loan Agreement
Graymark Healthcare, Inc.

     IN WITNESS WHEREOF, the parties have executed this Agreement effective the date first above written.

		GRAYMARK HEALTHCARE, INC., an Oklahoma Corporation
		By /S/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇                 ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, CEO
		APOTHECARYRx LLC, an Oklahoma limited liability company
		BY: GRAYMARK HEALTHCARE, INC., an Oklahoma Corporation, MANAGER
		By /S/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇                     ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, CEO
		SDC HOLDINGS, LLC, an Oklahoma limited liability company
		BY: GRAYMARK HEALTHCARE, INC., an Oklahoma Corporation, MANAGER
		By /S/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇                     ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, CEO
		(the “Borrowers”)
		▇▇▇▇▇▇ COMPANY HOLDINGS, LLC, an Oklahoma limited liability company
		By /S/ ▇▇▇ ▇. ▇▇▇▇▇▇      ▇▇▇ ▇. ▇▇▇▇▇▇, Manager
		/S/ ▇▇▇ ▇. ▇▇▇▇▇▇ ▇▇▇ ▇. ▇▇▇▇▇▇, individually

Loan Agreement
Graymark Healthcare, Inc.

		THE ▇▇▇ ▇. ▇▇▇▇▇▇ REVOCABLE TRUST DATED JUNE 15, 2004
		By /S/ ▇▇▇ ▇. ▇▇▇▇▇▇            ▇▇▇ ▇. ▇▇▇▇▇▇, Trustee
		/S/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, individually
		/S/ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇, individually
		/S/ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, individually
		/S/ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇, individually
		/S/ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇ ▇▇▇, individually
		/S/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇, individually
		(the “Guarantors”)
		ARVEST BANK, an Arkansas banking corporation
		By /S/ ▇▇▇▇▇ ▇▇▇▇           ▇▇▇▇▇ ▇▇▇▇, Senior Vice President
		(the “Bank”)

Loan Agreement
Graymark Healthcare, Inc.